Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 47

Sort by

Sort Order Select

Journal Articles

Evaluation of a Blood Coagulation Factor IX Variant That Functions Independently of Factor VIII As an Alternative Treatment for Hemophilia A

Viola J.F. Strijbis, MSc, Ka Lei Cheung, Pavlina Konstantinova, PhD, Ying Poi Liu, PhD, Sander J van Deventer, MD PhD, Mettine H.A. Bos, PhD

Blood (2019) 134 (Supplement_1): 1110.

https://doi.org/10.1182/blood-2019-124120

Published: 2019

Journal Articles

MAA868 locks factor XIa in a zymogen-like state

Jeffrey I. Weitz, Noel C. Chan

Blood (2019) 133 (13): 1393–1394.

https://doi.org/10.1182/blood-2019-02-900480

Published: 2019

Journal Articles

Prochemerin cleavage by factor XIa links coagulation and inflammation

Xiaomei Ge, Yasuto Yamaguchi, Lei Zhao, Loredana Bury, Paolo Gresele, Caroline Berube, Lawrence L. Leung, John Morser

Blood (2018) 131 (3): 353–364.

https://doi.org/10.1182/blood-2017-07-792580

Published: 2018

Includes: Supplemental data

Journal Articles

Prochemerin processing by factor XIa

Joost C. M. Meijers

Blood (2018) 131 (3): 275–276.

https://doi.org/10.1182/blood-2017-12-818989

Published: 2018

Journal Articles

Platelet-Based Factor VIII Activity Is Inhibited By Anti-C2 Domain Antibodies That Donâ€™t Significantly Inhibit Factor VIII Activity in a Standard Assay

Madhumouli Chatterjee, PhD, Shannon L. Meeks, MD, Valerie Anne Novakovic, MS, John S. Lollar, MD, Gary E Gilbert, MD

Blood (2017) 130 (Supplement 1): 2345.

https://doi.org/10.1182/blood.V130.Suppl_1.2345.2345

Published: 2017

Journal Articles

Prochemerin Cleavage By Factor XIa Links Adipogenesis, Inflammation and Coagulation

Xiaomei Ge, PhD, Yasuto Yamaguchi, Lei Zhao, MS, Loredana Bury, Paolo Gresele, Lawrence L. Leung, John Morser, PhD

Blood (2016) 128 (22): 2561.

https://doi.org/10.1182/blood.V128.22.2561.2561

Published: 2016

Journal Articles

Platelet Membranes and Activation Pathway Determine Inhibitory Activity of Anti-Factor VIII C2 Domain Antibodies

Madhumouli Chatterjee, PhD, Shannon L. Meeks, MD, Valerie Anne Novakovic, MS, Pete Lollar, MD, Gary E. Gilbert, MD

Blood (2016) 128 (22): 2567.

https://doi.org/10.1182/blood.V128.22.2567.2567

Published: 2016

Journal Articles

Proteolytic Inactivation of ADAMTS13 By Activated Factor XI

Kathleen Garland, MD, Owen J.T. McCarty, PhD, Cristina Puy, PhD

Blood (2016) 128 (22): 4955.

https://doi.org/10.1182/blood.V128.22.4955.4955

Published: 2016

Journal Articles

Detection of Factor IXa Activity By the Enhanced Thrombin Generation Assay

Pansakorn Tanratana, MD, John P. Sheehan, MD

Blood (2014) 124 (21): 4242.

https://doi.org/10.1182/blood.V124.21.4242.4242

Published: 2014

Journal Articles

Coagulation Factor XI and Factor XII in DNA-Induced Thrombin Generation

Anton Matafonov, MD, Ivan S. Ivanov, PhD, Mao-fu Sun, David Gailani, MD

Blood (2014) 124 (21): 581.

https://doi.org/10.1182/blood.V124.21.581.581

Published: 2014

Journal Articles

The Serpins C1-Inhibitor and Antithrombin Synergistically Regulate the Catalytic Life of Activated Factor XI in Healthy Individuals and Thrombophilic Patients

Heiko Rühl, MD, Jens Müller, PhD, Johannes Oldenburg, MD PhD, Bernd Pötzsch, MD PhD

Blood (2014) 124 (21): 1475.

https://doi.org/10.1182/blood.V124.21.1475.1475

Published: 2014

Journal Articles

Desmolaris, a novel factor XIa anticoagulant from the salivary gland of the vampire bat ( Desmodus rotundus ) inhibits inflammation and thrombosis in vivo

Dongying Ma, Daniella M. Mizurini, Teresa C. F. Assumpção, Yuan Li, Yanwei Qi, Michail Kotsyfakis, José M. C. Ribeiro, Robson Q. Monteiro, Ivo M. B. Francischetti

Blood (2013) 122 (25): 4094–4106.

https://doi.org/10.1182/blood-2013-08-517474

Published: 2013

Includes: Supplemental data

Journal Articles

Factor XI Deficiency Reduces The Inflammatory Response To Polymicrobial Sepsis In Mice

Charles E. Bane, jr., DVM, Kelli L. Boyd, DVM, Ph.D., Erik I. Tucker, Ph.D., Stephen T. Smiley, Ph.D., Andras Gruber, MD, David Gailani, MD

Blood (2013) 122 (21): 201.

https://doi.org/10.1182/blood.V122.21.201.201

Published: 2013

Journal Articles

Comparison Of Plasma Kallikrein Inhibition By The Endogenous C1-Inhibitor Versus DX-2930, a Monoclonal Antibody Inhibitor

Daniel J Sexton, Jon A Kenniston, Ryan R Faucette, Andrew E Nixon, Chris TenHoor, Yung Chyung, Burt Adelman

Blood (2013) 122 (21): 1066.

https://doi.org/10.1182/blood.V122.21.1066.1066

Published: 2013

Journal Articles

Thrombin Generation Responses to Human Factor XIa in Plasma of Animal Species

Yideng Liang, MD, Evi B Struble, PhD, Li Ma, Samuel A Woodle, Naveen Jha, PhD, Dorothy Scott, MD, Timothy K Lee, PhD, Mikhail V Ovanesov, PhD

Blood (2012) 120 (21): 5142.

https://doi.org/10.1182/blood.V120.21.5142.5142

Published: 2012

Journal Articles

The kunitz protease inhibitor domain of protease nexin-2 inhibits factor XIa and murine carotid artery and middle cerebral artery thrombosis

Wenman Wu, Hongbo Li, Duraiswamy Navaneetham, Zachary W. Reichenbach, Ronald F. Tuma, Peter N. Walsh

Blood (2012) 120 (3): 671–677.

https://doi.org/10.1182/blood-2012-03-419523

Published: 2012

Journal Articles

Chemerin Bioactivity Is Regulated by Factor XIa: A Novel Interface Linking Between Coagulation, Hemostasis and Immunity

Yasuto Yamaguchi, PhD, John Morser, PhD, Lawrence L. Leung, MD

Blood (2011) 118 (21): 2258.

https://doi.org/10.1182/blood.V118.21.2258.2258

Published: 2011

Journal Articles

Exosite Interactions in Factor IX Activation by Factor XIa

Yipeng Geng, Ingrid M. Verhamme, PhD, Stephen B. Smith, PhD, Amanda S. Messer, Mao-fu Sun, S. Paul Bajaj, David Gailani, MD

Blood (2011) 118 (21): 2235.

https://doi.org/10.1182/blood.V118.21.2235.2235

Published: 2011

Journal Articles

Plasma Serum Amyloid A Levels Are Increased In Venous Thrombosis Patients and Are Correlated with Blood Coagulability

Hiroshi Deguchi, MD, PhD, Darlene J Elias, MD, Silvia Navarro, PhD, Francisco Espana, PhD, John H. Griffin, PhD

Blood (2010) 116 (21): 155.

https://doi.org/10.1182/blood.V116.21.155.155

Published: 2010

Journal Articles

Covalent End-Labeling of Polyphosphate Facilitates Studies of Its Procoagulant Activities and Development of Enhanced Agents to Treat Bleeding.

Sharon H Choi, MS, Rebecca L Davis-Harrison, PhD, Stephanie A. Smith, DVM, MS, Julie N.R. Collins, MS, Chad M Rienstra, PhD, James H. Morrissey, PhD

Blood (2010) 116 (21): 1138.

https://doi.org/10.1182/blood.V116.21.1138.1138

Published: 2010

NARROW

Evaluation of a Blood Coagulation Factor IX Variant That Functions Independently of Factor VIII As an Alternative Treatment for Hemophilia A

MAA868 locks factor XIa in a zymogen-like state

Prochemerin cleavage by factor XIa links coagulation and inflammation

Prochemerin processing by factor XIa

Platelet-Based Factor VIII Activity Is Inhibited By Anti-C2 Domain Antibodies That Donâ€™t Significantly Inhibit Factor VIII Activity in a Standard Assay

Prochemerin Cleavage By Factor XIa Links Adipogenesis, Inflammation and Coagulation

Platelet Membranes and Activation Pathway Determine Inhibitory Activity of Anti-Factor VIII C2 Domain Antibodies

Proteolytic Inactivation of ADAMTS13 By Activated Factor XI

Detection of Factor IXa Activity By the Enhanced Thrombin Generation Assay

Coagulation Factor XI and Factor XII in DNA-Induced Thrombin Generation

The Serpins C1-Inhibitor and Antithrombin Synergistically Regulate the Catalytic Life of Activated Factor XI in Healthy Individuals and Thrombophilic Patients

Desmolaris, a novel factor XIa anticoagulant from the salivary gland of the vampire bat ( Desmodus rotundus ) inhibits inflammation and thrombosis in vivo

Factor XI Deficiency Reduces The Inflammatory Response To Polymicrobial Sepsis In Mice

Comparison Of Plasma Kallikrein Inhibition By The Endogenous C1-Inhibitor Versus DX-2930, a Monoclonal Antibody Inhibitor

Thrombin Generation Responses to Human Factor XIa in Plasma of Animal Species

The kunitz protease inhibitor domain of protease nexin-2 inhibits factor XIa and murine carotid artery and middle cerebral artery thrombosis

Chemerin Bioactivity Is Regulated by Factor XIa: A Novel Interface Linking Between Coagulation, Hemostasis and Immunity

Exosite Interactions in Factor IX Activation by Factor XIa

Plasma Serum Amyloid A Levels Are Increased In Venous Thrombosis Patients and Are Correlated with Blood Coagulability

Covalent End-Labeling of Polyphosphate Facilitates Studies of Its Procoagulant Activities and Development of Enhanced Agents to Treat Bleeding.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only